Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine with dexmedetomidine for postoperative analgesia after cesarean section
ChiCTR2500096770Phase 4Not yet recruiting
- Sponsor
- Nanchong City Central Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine and dexmedetomidine in postoperative pain and sleep disorder (3 arms), sponsored by Nanchong City Central Hospital. Primary endpoint: Sleep quality. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
postoperative painsleep disorder
Beyond the preview
Go deeper on ChiCTR2500096770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096770.